Reading the Numbers Right: Which Blood Tests Genuinely Forecast Erectile Dysfunction—and Which Are a Waste of Your Time

The direct-to-consumer health testing market in the United States has grown dramatically over the past decade. Men can now order panels online, visit walk-in labs without a physician's referral, and receive dozens of biomarkers in a digital dashboard—often accompanied by vague warnings and upsells for supplements or hormone therapies. For men concerned about erectile dysfunction, navigating this landscape requires a clear understanding of which numbers actually matter.

The truth is that a relatively small set of well-established laboratory markers carries genuine predictive and diagnostic value for ED. Understanding what to ask for—and how to interpret what comes back—is a skill that can meaningfully improve both the quality of a man's conversation with his physician and the efficiency of his diagnostic workup.

Why Blood Work Matters for ED in the First Place

Erectile dysfunction is not simply a mechanical problem. In the majority of men over 40, it has a vascular, metabolic, or hormonal component that is detectable through laboratory testing. Research has consistently shown that ED frequently precedes a cardiovascular event by several years, functioning as an early warning signal for systemic arterial disease. This means that a man who proactively investigates the biochemical underpinnings of his ED may catch a much more serious health problem before it becomes life-threatening.

With that context in mind, here is what the evidence supports.

Markers With Genuine Predictive Value

Fasting Lipid Panel

A standard lipid panel—measuring total cholesterol, LDL, HDL, and triglycerides—remains one of the most informative tests a man with ED can obtain. Elevated LDL cholesterol and low HDL are strongly associated with endothelial dysfunction, the impaired arterial response that underlies most vascular ED. Atherosclerotic plaque formation in the penile arteries follows the same pathophysiological process as coronary artery disease, and lipid abnormalities often precede clinical symptoms by years.

The penile arteries are significantly smaller in diameter than the coronary arteries, which means they are often the first vessels to show signs of atherosclerotic narrowing. A man with borderline lipid values and ED may have subclinical cardiovascular disease that has not yet produced chest pain or shortness of breath.

Fasting Glucose and HbA1c

Diabetes and pre-diabetes are among the most potent risk factors for erectile dysfunction, operating through both vascular and neurological mechanisms. Chronically elevated blood glucose damages the small blood vessels and nerves that support erectile function, often before a formal diabetes diagnosis has been made.

Fasting plasma glucose provides a snapshot of blood sugar control, while HbA1c (glycated hemoglobin) reflects average glucose levels over the preceding two to three months. Together, these two values give a physician a much more complete picture of metabolic health than either test alone. Men with HbA1c values in the pre-diabetic range (5.7–6.4%) should treat this as a significant finding in the context of ED.

Total and Free Testosterone

As discussed extensively in endocrinological literature, testosterone deficiency is a genuine cause of sexual dysfunction in a subset of men. A morning total testosterone level, obtained ideally on two separate occasions, is the appropriate first step. Because much of circulating testosterone is bound to proteins and therefore biologically inactive, free testosterone measurement adds diagnostic value—particularly in men with borderline total levels or significant obesity, which can elevate sex hormone-binding globulin.

The key is contextualizing the result. A total testosterone of 280 ng/dL in a symptomatic man is clinically meaningful. The same value in a man with no other symptoms of hypogonadism may warrant monitoring rather than immediate treatment.

Complete Metabolic Panel

A basic or comprehensive metabolic panel assesses kidney function, liver enzymes, and electrolyte balance. While not a direct predictor of ED, this panel is important for two reasons. First, chronic kidney disease has a well-established association with erectile dysfunction. Second, liver function values are relevant before initiating many ED medications or hormone therapies, as both are processed hepatically.

High-Sensitivity C-Reactive Protein (hs-CRP)

Systemic inflammation is an increasingly recognized contributor to vascular ED. High-sensitivity CRP, a marker of low-grade chronic inflammation, has been associated with endothelial dysfunction in multiple studies. Men with elevated hs-CRP who are otherwise metabolically healthy may benefit from anti-inflammatory lifestyle interventions—dietary changes, exercise, stress reduction—that can improve both inflammatory markers and erectile function over time.

Prolactin

Elevated prolactin levels, a condition called hyperprolactinemia, can suppress testosterone production and directly impair sexual function. It is not a first-line test for every man with ED, but it is appropriate when testosterone levels are low without a clear explanation, or when the clinical picture includes reduced libido, visual disturbances, or unexplained headaches that might suggest a pituitary adenoma.

Markers That Are Frequently Overstated

Estradiol (in Isolation)

Some consumer-facing men's health platforms have leaned heavily on estradiol testing as a driver of supplement sales. While estradiol balance is relevant in the context of testosterone therapy, an isolated estradiol level in a man not on exogenous hormones is rarely actionable on its own. The clinical significance of mildly elevated estradiol in otherwise healthy men remains a subject of genuine debate among endocrinologists.

Comprehensive "Male Hormone Panels"

Many direct-to-consumer lab services offer expansive hormone panels that include DHEA-S, pregnenolone, and numerous other precursor hormones at considerable expense. While some of these markers have research applications, their clinical utility for diagnosing or managing ED in routine practice is limited. A focused panel ordered by a physician with clinical context will almost always yield more actionable information than a broad consumer panel interpreted without medical oversight.

Genetic Testing for ED Risk

Several companies now offer genetic panels purporting to assess a man's risk for erectile dysfunction based on polymorphisms in nitric oxide synthesis or androgen receptor genes. While the underlying science is legitimate, the predictive power of these tests at the individual level is currently insufficient to guide clinical decision-making. They are best regarded as research tools rather than diagnostic instruments.

Having the Conversation With Your Doctor

Armed with this information, men can approach their primary care physician or urologist with a focused and productive request. A reasonable starting panel for a man with ED who has not yet undergone workup might include: fasting lipids, fasting glucose and HbA1c, morning total and free testosterone, a basic metabolic panel, and hs-CRP. If testosterone is low, adding prolactin and LH is appropriate.

This panel is affordable, widely available through standard insurance coverage, and yields genuinely actionable data. It positions both the patient and the physician to make informed decisions about whether ED is primarily vascular, metabolic, hormonal, or multifactorial in origin—and to chart a treatment course accordingly.

The goal is not to accumulate data. It is to understand what the data means and act on it intelligently.